Changes to legislation, NHS reforms and how pharma can support healthcare going forward.
LATEST >
Patient pathways: Tracing a collaborative path to high quality care
"To meet the challenges of COVID-era healthcare, patient pathways – from diagnostics to treatment, monitoring to follow-up – have been transformed"
NHS rolls out drug reported to be the most expensive in the world
The NHS has struck a deal for a revolutionary gene therapy treatment, reportedly the most expensive drug in the world, that will offer babies...
- Advertisement -
Triumphs and tribulations: a forecast for 2022
As we move into an uncertain 2022, Wilmington Healthcare’s Oli Hudson picks out three underlying themes that are likely to influence the way industry...
- Advertisement - 
- Advertisement - 
Vaccine passports, technology and trust: is the NHS heading in the right direction?
"The NHS should concentrate its resource on clinical settings and clinical outcomes and rely on technology companies to bring in existing and viable innovations"
Adapting for success: Understanding commercial optimisation
"Commercial optimisation can be transformative for pharmaceutical companies’ bottom line"
NHS receives extra £5.4 billion to support COVID-19 response over next 6 months
The Prime Minister and Health and Social Care Secretary Sajid Javid have announced that...
Patient management in a digital world
It is well established that the COVID-19 pandemic accelerated the digital evolution of the...
